At a time when Cramer keeps telling investors to get involved with all things health care, he introduced investors to a company that is a bit further up on the health care food chain as a high quality life sciences company.
Thermo Fisher Scientific is the top player in the life sciences tools business. It provides lab customers with everything needed to conduct real science, offering a substantial diagnostics division, an environmental and food safety business and a genomics platform.
"Think of Thermo Fisher as an arms dealer for biotech and pharmaceutical companies," Cramer said.
The company even managed to report a very strong quarter back in April, even though it was hit hard by the strength of the dollar. Could currency impact the potential upside to the stock? To find out, Cramer spoke with Thermo Fisher Scientific CEO Marc Casper.
"From a currency perspective, I think all of the multi-nationals are facing it, but we are navigating it effectively. In fact, this year we should have 4 to 6 percent earnings growth despite some currency headwinds," Casper said.
As Cramer has said many times recently, we are in a no-win environment when it comes to economic growth. Either the economy will continue to slow, or the Fed will raise interest rates and slam the brakes on commerce in this country in order to make the superfreakin' dollar stronger than it already is.
Unfortunately, one of these two scenarios is very likely to become reality, but that does not mean all stocks need to take a nose dive as a result. A low-growth environment can be good news for companies with consistent growth, as investors will soon flock to them.
"I think we are going to see huge piles of money pour into these consistent, secular growth cohorts that tend to dramatically outperform the rest of the market during a slowdown," the "Mad Money" host said. (Tweet This)
With this in mind, Cramer's favorite secular growth theme right now is the health-care cost-containment plays. Health care is one group that remains consistent, as people still will not cut back even when they feel less wealthy. The cost containment plays are some of the fastest growers because health-care costs have become such a huge problem in America.
This week, Cramer will focus on his three favorite wholesale drug distribution companies, which play a huge role in containing health-care costs. Cardinal Health is a very acquisitive company that acts as both a wholesale supplier of drugs and medical supplies, including everything from surgical apparel to gloves to fluid-management products.
"If the company can keep making these small but meaningful acquisitions over time, then I could see the stock ultimately trading much higher. Plus, I think Cardinal could potentially be an attractive takeover candidate for its larger and better capitalized competitor McKesson," Cramer added.
Read More Cramer: Huge piles of money about to pour into this
In the Lightning Round, Cramer gave his take on a few caller favorite stocks:
PNC Financial Services Group: "You're right to buy it. Here's the problem—it just hit a 52-week high today. I think the market is headed down for a couple of days, but that's a great place to be."
Royal Caribbean Cruises: "I like Royal but I have to tell you, I saw Carnival Corp last week and I am quite taken by Carnival. I prefer you to be in that one."
Read MoreLightning Round: These stocks are under pressure
Correction: This article has been updated to reflect Cramer's mantra to hold Apple, not trade it.